Not Signed In - Bad Cholesterol In Patients With Type II Diabetes Studied In Mayo Clinic Proceedings
Thu, 28 Dec 2006 08:00 AM EST
... Results from a clinical study conducted in 1,229 patients with type II diabetes mellitus and high cholesterol showed that VYTORIN® (ezetimibe/simvastatin) provided superior reduction in LDL "bad" cholesterol compared to Lipitor® (atorvastatin) at the dose comparisons studied, according to data published in the December 2006 issue of Mayo Clinic Proceedings. [click link for full article] ...
Related Topics
- Juvenile Diabetes
- Diabetes - Type 1
- Diabetes - Type 2
- Diabetes and Pregnancy
- High Cholesterol
- Diabetes
- The Mayo Clinic Plan
- Mayo Clinic Diet
- Cholesterol
- LDL
- Halitosis
- Mucopolysaccharidosis
- Diabetes Insipidus
- Kniest dysplasia
- Gestational Diabetes
- Nutrition Topics
- Insulin
- Coronary artery disease (from diabetes and high cholesterol)
- Increased risk of heart attack from untreated diabetes and high cholesterol
- Cockayne Syndrome Type II
email this page
print this page
bookmark this page
feedback on this page
